New partnerships enable hospitals to access the Imagia EVIDENS™ AI platform, empowering clinicians to utilize cohorted and structured real world data to achieve new medical insights via federated learning.
Created by leading financiers wanting to combine academic research and industry expertise, the Onco-Tech Competition is an opportunity for Quebec investigators to accelerate the development, validation and marketing of new medical technologies i
...Led by Imagia and The Terry Fox Research Institute, the network with $108M in-cash and $165M in-kind contributions will connect almost 100 partners across Canada, including health care institutions; small, medium-sized and large companies; uni
...On May 23, Navdeep Bains, the innovation minister, attended C2 and then drove across town to give $49 million to a Montreal-based outfit called Imagia, which is fronting a group that intends to use artificial intelligence (AI) to process health
...The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, announced an investment of up to $49M from the Strategic Innovation Fund (SIF) as part of the Stream 4 – Health and Biosciences competition. This award, to
...Montreal startup Imagia aims to create a Canada-wide health data platform. In collaboration with the Terry Fox Research Institute and a $49 million grant from the Canadian government, they will make personalized health care a clinical reality.
“The time to harness the power of AI is now so that we continue to augment Canada’s position on the global AI stage,” said Alexandre Le Bouthillier, founder of Imagia, which made Betakit’s 10 Montreal Startups to Watch list. “By comb
...Imagia develops treatment solutions for the pharmaceutical and medical equipment industries. The goal? To make personalized medical care accessible to all. The company uses artificial intelligence to facilitate access care for cancer patients.
Six Montréal-based companies to scale up and expand into new markets.
The Government of Canada is committed to supporting Canada’s high growth-potential businesses to innovate, to increase their productivity and competitiveness, and to access
Imagia teams with pharma, diagnostic, and interventional medical device companies to co-develop healthcare AI products and drive the future of personalized healthcare around the world.
Evidens is Imagia’s collaborative AI ecosystem led by clin
...Please complete the form in order to direct your request to the appropriate department, and we will reach out as soon as possible.